Forest Ray

Long Beach, Los Angeles

Science Writer at BioNews Services

Science Writer at Multiple Sclerosis News Today

Freelance Journalist at zoho.com

Featured in: Favicon

bionews.com Favicon

multiplesclerosisnewstoday.com Favicon

nationalgeographic.com Favicon

hakaimagazine.com Favicon

theecologist.org Favicon

genomeweb.com Favicon

realclearscience.com Favicon

earthisland.org Favicon

alzheimersnewstoday.com + 38 more

Articles

Methylation Patterns Zero in on Cell Types, Cellular Mechanisms Involved in Liver Transplant Rejection

1 week ago | genomeweb.com | Forest Ray

NEW YORK – Methylation patterns found in circulating cell-free DNA (cfDNA) may provide researchers with a finer look at the cell types involved in liver transplant rejection, as well as specific causes of allograft injury. Most current molecular transplant rejection assays monitor transplant health using differences between single-nucleotide polymorphisms (SNPs) found on donor and recipient cfDNA.
Computational Tool Opens Window Into 'Dark Proteome,' Enhancing Biomarker Discovery

1 week ago | genomeweb.com | Forest Ray

NEW YORK – A new computational tool offers a way to efficiently identify protein variations that other methods often overlook, thereby expanding scientists' ability to detect disease-associated mutations. Paul Boutros, professor of urology and human genetics at the University of California, Los Angeles, said that the method, called moPepGen (multi-omics peptide generator), allows researchers to make use of significantly more of the data generated in mass spectrometry experiments.
Phase Scientific Plans Large Study of Urine-Based HPV Test as Cervical Cancer Screen

2 weeks ago | 360dx.com | Forest Ray

NEW YORK – Molecular diagnostics company Phase Scientific is gearing up to launch a large-scale study of its urine-based human papillomavirus (HPV) test in China for cervical cancer screening on the heels of positive clinical validation data earlier this year.
Phase Scientific Plans Large Study of Urine-Based HPV Test as Cervical Cancer Screen

2 weeks ago | genomeweb.com | Forest Ray

NEW YORK – Molecular diagnostics company Phase Scientific is gearing up to launch a large-scale study of its urine-based human papillomavirus (HPV) test in China for cervical cancer screening on the heels of positive clinical validation data earlier this year.
Experts at ASCO Highlight Value of Genomic, Transcriptomic Analyses in Newborn Screening

3 weeks ago | genomeweb.com | Forest Ray

NEW YORK – Genomic analysis is poised to play a greater role in newborn screening (NBS), according to experts who shared data from childhood cancer studies at the annual meeting of the American Society of Clinical Oncology in Chicago.
Evidence for ctDNA as Breast Cancer Progression Marker Builds But More Data Still Needed

3 weeks ago | genomeweb.com | Forest Ray

NEW YORK – Data from several clinical trials presented at the American Society of Clinical Oncology's annual meeting this week support the use of circulating tumor DNA (ctDNA) to guide therapy decisions before clinical progression in early and metastatic breast cancer.
Geneseeq Prepares for Broader Commercialization of Fragmentomic MCED, Single-Cancer Tests

4 weeks ago | genomeweb.com | Forest Ray

NEW YORK – Geneseeq sees a path to broader commercialization of its CanScan liquid biopsy multicancer early detection (MCED) test, following encouraging interim data from an ongoing multiphase study taking place in China that was published this week in Nature. The multiphase study aims to determine the feasibility of MCED testing using Geneseeq's CanScan assay in an outpatient setting, targeting asymptomatic adults between the ages of 45 and 75.
Cell Segmentation Method From Fred Hutch Team May Improve Spatial Biology Accuracy

1 month ago | genomeweb.com | Forest Ray

NEW YORK – A novel cell segmentation method developed by scientists at the Fred Hutchinson Cancer Center may help researchers conduct more accurate spatial biology studies, advancing key efforts such as cancer biomarker and drug target discovery. Cell segmentation is a fundamental first step in understanding spatial gene expression; essentially, which mRNA transcripts come from which cell.
Mindera Health Psoriasis Therapy Response Test Changes Physician Behavior in Clinical Utility Study

1 month ago | genomeweb.com | Forest Ray

NEW YORK – Skin analytics company Mindera Health recently demonstrated the clinical utility of its flagship Mind.Px lab-developed test and is now focused on expanding its access while planning a longer durability study. The Mind.Px test consists of a patch, approximately the size of a penny, covered with a 10-by-10 array of minuscule needle-like projections that are pushed via an applicator 350 to 400 micrometers into the skin and held for five minutes.
Global Genomics Medicine Collaborative at End of Funding Line, May Cease Operations Soon

1 month ago | genomeweb.com | Forest Ray

NEW YORK – Without a significant cash infusion, international genomics research nonprofit Global Genomics Medicine Collaborative (G2MC) runs out of money and will likely have to close its operations in approximately nine weeks' time.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →